Mr. Genuis, thanks very much; I appreciate that.
There has been, however, a question of relevance raised by one of our colleagues, a member of the committee, and we should have a survey of the committee's view on this. in case the committee wishes to change its orientation away from COVAX. I don't think that's the case, but let's hear from Dr. Fry and Mr. Fonseca briefly, and Ms. Sahota.